HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium.

Abstract
Matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs) have been recognized to play a pivotal role in matrix remodeling following myocardial infarction (MI). The aims of the present study were to examine the expression profile of MMPs/TIMP-1 after MI and to determine whether angiotensin II receptor (ATR) blockade improves MMPs/TIMP-1 balance. Compared with sham-operated rats, in vivo MI-induced a significant elevation of MMP-2, MMP-3 and MMP-9 levels and a marked reduction of TIMP-1 and fibronectin (FN) expressions in infarcted left ventricular free wall (LVFW) and hypertrophic interventricular septum (IS) but not in non-infarcted right ventricle (RV). In addition, regional MI increased MMP-2, MMP-3 and MMP-9, while decreased TIMP-1 and FN in infarcted LVFW and hypertrophic IS compared with the non-infarcted RV. Compared with vehicle-treated MI rats, oral valsartan, but not PD123319, limited infarct size, normalized MMPs/TIMP-1 balance and restored FN level. The present findings might further our understanding of the regulatory mechanisms of valsartan in myocardial remodeling after MI.
AuthorsDachun Yang, Shuangtao Ma, De Li, Bing Tang, Yongjian Yang
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 388 Issue 3 Pg. 606-11 (Oct 23 2009) ISSN: 1090-2104 [Electronic] United States
PMID19695229 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Fibronectins
  • Imidazoles
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • Tetrazoles
  • Tissue Inhibitor of Metalloproteinase-1
  • PD 123319
  • Valsartan
  • Matrix Metalloproteinases
  • Valine
Topics
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Fibronectins (biosynthesis)
  • Imidazoles (pharmacology)
  • Male
  • Matrix Metalloproteinases (metabolism)
  • Myocardial Infarction (metabolism, pathology)
  • Pyridines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptor, Angiotensin, Type 1 (drug effects, metabolism)
  • Tetrazoles (pharmacology)
  • Tissue Inhibitor of Metalloproteinase-1 (metabolism)
  • Valine (analogs & derivatives, pharmacology)
  • Valsartan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: